Top
News Updates

SC dismisses PIL against Ranbaxy; Petitioner to file fresh Petition against Ranbaxy

Live Law News Network
25 Jun 2013 10:28 AM GMT
SC dismisses PIL against Ranbaxy; Petitioner to file fresh Petition against Ranbaxy
x
Your free access to Live Law has expired
To read the article, get a premium account.
    Your Subscription Supports Independent Journalism
Subscription starts from
599+GST
(For 6 Months)
Premium account gives you:
  • Unlimited access to Live Law Archives, Weekly/Monthly Digest, Exclusive Notifications, Comments.
  • Reading experience of Ad Free Version, Petition Copies, Judgement/Order Copies.
Already a subscriber?
The Supreme Court today dismissed a PIL [WP (Criminal) 98 of 2013] filed against pharma company Ranbaxy, for allegedly manufacturing and selling substandard drugs in India, due to lack of sufficient evidence against the company.

A Supreme Court Bench comprising of Justices A K Patnaik and Ranjan Gogoi said, “Your entire argument is based on proceedings in US. We have no jurisdiction over it. Show us material that things are happening in India and it adversely affects right to life of people here."

Ranbaxy USA had admitted to selling substandard and adulterated drugs and was asked to pay a fine of 500 million dollars by the US Food and Drug Administration (USFDA).

The petition was filed by Supreme Court lawyer, Manohar Lal Sharma. Speaking to Live Law Sharma said, “The Court has not dismissed my petition but has only asked to bring more evidence and file a fresh petition. I will be re-filing soon as directed by the Court.”



 

 
Next Story